CD40增强眼眶成纤维细胞鞘脂代谢:S1P在GO中T细胞迁移的作用
该研究探讨CD40信号在Graves眼病(GO)眼眶成纤维细胞中诱导S1P活性的作用。GO眼眶组织S1P水平高于对照,CD40配体刺激仅使GO来源成纤维细胞S1P表达增加,并增强ASM和鞘氨醇激酶活性,S1P可吸引T细胞迁移,提示S1P受体信号调节剂可用于GO管理。
要点
- GO眼眶组织S1P水平高于健康对照。
- CD40配体仅刺激GO成纤维细胞产生S1P,对照不受影响。
- S1P介导GO成纤维细胞对T细胞的趋化吸引。
核心结论
- CD40配体刺激GO成纤维细胞产生S1P,S1P是驱动T细胞迁移的因素,支持S1P受体信号调节剂用于GO管理。
研究设计与样本
- 实验研究,比较GO患者与健康对照来源的眼眶成纤维细胞和T细胞,采用免疫荧光、ELISA、超高效液相色谱、质谱和T细胞迁移实验。
主要发现
- GO眼眶组织S1P含量高于对照样本。
- CD40刺激诱导GO来源成纤维细胞S1P表达,对照来源成纤维细胞不受影响。
- GO来源成纤维细胞中ASM和鞘氨醇激酶活性及脂质形成显著增加。
- 鞘氨醇激酶抑制剂存在下T细胞迁移实验显示GO成纤维细胞释放的S1P吸引T细胞迁移。
临床怎么用
- 研究结果支持将S1P受体信号调节剂用于GO管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Graves' orbitopathy (GO) is an autoimmune orbital disorder associated with Graves' disease caused by thyrotropin receptor autoantibodies. Orbital fibroblasts (OFs) and CD40 play a key role in disease pathogenesis. The bioactive lipid sphingosine-1-phosphate (S1P) has been implicated in promoting adipogenesis, fibrosis, and inflammation in OFs. We investigated the role of CD40 signaling in inducing S1P activity in orbital inflammation. METHODS: OFs and T cells were derived from GO patients and healthy control (Ctl) persons. S1P abundance in orbital tissues was evaluated by immunofluorescence. OFs were stimulated with CD40 ligand and S1P levels were determined by ELISA. Further, activities of acid sphingomyelinase (ASM), acid ceramidase, and sphingosine kinase were measured by ultraperformance liquid chromatography. Sphingosine and ceramide contents were analyzed by mass spectrometry. Finally, the role for S1P in T-cell attraction was investigated by T-cell migration assays. RESULTS: GO orbital tissue showed elevated amounts of S1P as compared to control samples. Stimulation of CD40 induced S1P expression in GO-derived OFs, while Ctl-OFs remained unaffected. A significant increase of ASM and sphingosine kinase activities, as well as lipid formation, was observed in GO-derived OFs. Migration assay of T cells in the presence of SphK inhibitor revealed that S1P released by GO-OFs attracted T cells for migration. CONCLUSIONS: The results demonstrated that CD40 ligand stimulates GO fibroblast to produce S1P, which is a driving force for T-cell migration. The results support the use of S1P receptor signaling modulators in GO management.
引用
- Plöhn S, Edelmann B, Japtok L, et al. CD40 Enhances Sphingolipids in Orbital Fibroblasts: Potential Role of Sphingosine-1-Phosphate in Inflammatory T-Cell Migration in Graves' Orbitopathy. Invest Ophthalmol Vis Sci. 2018. PMID: 30452592. doi:10.1167/iovs.18-25466
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。